Abstract
Summary
The present report confirms the findings by Steinberg et al. (9) that repeated intraperitoneal injections of poly I:C (3 μg/g, three times per wk, 40-52 doses) enhanced the incidence and severity of glomer-ular lesions that occur spontaneously in NZB/NZW mice and also increased the development of circulating antibody against nucleic acids. This effect was minimal when only six intraperitoneal doses were given in 1 μg/g amount at weekly intervals. Intra-nasal administration of poly I:C (0.2 μg/g, three times per wk, 40 doses) or six doses of the drug (1 μg/g weekly) caused no apparent potentiation of glomerular response. ICR/ Ha mice, which do not suffer from the spontaneously occurring disease, were unaffected by poly I:C treatment except for occasional development of antibody against poly I:C or DNA.
Skilled technical assistance was provided by M. E. Davies, H. Perry, F. Roach, W. P. M. Fisher, M. Johnston, R. Civera, J. A. Duddy, and S. H. Kulp.
Get full access to this article
View all access options for this article.
